Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NHS England agree to pay for Biogen's $750,000 a year SMA treatment Spinraza

pharmafileMay 16, 2019

Tag: NHS , sma , Spinraza

PharmaSources Customer Service